Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
Conditions
- Carcinoma, Hepatocellular
Interventions
- DRUG: Mapatumumab
- DRUG: Placebo
- DRUG: Sorafenib
Sponsor
Human Genome Sciences Inc., a GSK Company
Collaborators